Salomon & Ludwin »

Nektar Therapeutics shares owned by Salomon & Ludwin

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Salomon & Ludwin from 13F filings

Historical chart of Salomon & Ludwin investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Salomon & Ludwin consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Salomon & Ludwin

Quarter filed Position value Share count Share price at filing
2025-09-30 $182 3 60.67
2025-06-30 $77 3 25.67

More positions owned by Salomon & Ludwin

Ishares S&p 500 Growth Etf (IVW)
Ishares Short Term Ntnl Etf (SUB)
Technology Select Sector Etf (XLK)
Jpmorgan Ultra Shrt Etf (JMST)
Vanguard S&p 500 Etf Etf (VOO)
Spdr Bloomberg 1 3 Mnth Etf (BIL)
Ishares S&p 500 Value Etf (IVE)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Etf (SPY)
Vanguard Ftse Developed Etf (VEA)
Ishares Core S&p Mid Cap Etf (IJH)
Vanguard Muni Bnd Tax Etf (VTEB)
Vanguard Short Term Etf (VGSH)
Ishares Msci Eafe Etf Etf (EFA)
Ishares National Muni Etf (MUB)

View all positions for Salomon & Ludwin

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics